Cognition Therapeutics CGTX
NASDAQ CGTX
$0.68 +0.01 (+1.06%)
At close: Nov 11, 2026 · 4:00 PM EST

Cognition Therapeutics (CGTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Cognition Therapeutics (CGTX) reported Return on Capital Employed [ROCE] of -114.14% for Q2 2026, up 461.48 percentage points from -575.61% a year earlier and up 4.17 percentage points from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Cognition Therapeutics posted Return on Capital Employed [ROCE] of -188.27%, up 62.07 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -75.08 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -250.35% in FY2024 (-94.87 pp), -155.48% in FY2023 (-62.79 pp), -92.69% in FY2022 (+20.51 pp) and -113.20% in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +25.32 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 461.48 percentage points); the low point was Q2 2025 (a drop of 347.06 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -118.31% (Q1 2026), -149.52% (Q4 2025) and -180.45% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Cognition Therapeutics 63.72 Mn -68.99 Mn - -118.54%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -118.54%
Jun 30, 2026 -114.14%
Mar 31, 2026 -118.31%
Dec 31, 2025 -149.52%
Sep 30, 2025 -180.45%
Jun 30, 2025 -575.61%
Mar 31, 2025 -336.99%
Dec 31, 2024 -303.79%
Sep 30, 2024 -319.84%
Jun 30, 2024 -228.55%
Mar 31, 2024 -203.07%
Dec 31, 2023 -189.28%
Sep 30, 2023 -135.30%
Jun 30, 2023 -115.77%
Mar 31, 2023 -106.24%
Dec 31, 2022 -98.54%
Sep 30, 2022 -112.15%
Jun 30, 2022 -79.00%
Mar 31, 2022 -63.25%
Dec 31, 2021 -100.70%
API Access

Cognition Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CGTX&period=max&api_key=YOUR_API_KEY